Exchange: OTC·Updated 02:12 PM EST

INIS International Isotopes Inc.

$0.035
$0.0001
(0.28%)
Today
Mkt Cap$18.98M
Vol186,960.00

About INIS

Radnostix, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. It operates through the following segments: Theranostics Products, Cobalt Products, Calibration & Reference Products, Medical Devices, and Fluorine Products. The Theranostics Products segment includes the production and distribution of various isotopically pure radiopharmaceuticals, APIs, and radiochemical for medical, industrial, and research applications. The Cobalt Products segment includes the production of various cobalt-60 products and service. The Calibration & Reference Products segment consists of various sealed source calibration and reference products, including own manufactured products, jointly manufactured products, and third-party products. The Medical Devices segment is currently under development. The Fluorine Products segment supports production and sale of various fluoride gases produced using Fluorine Extraction Process. The company was founded in November 1995 and is headquartered in Idaho Falls, ID.
50

Neutral Sentiment

How do you feel about INIS?

Rayvio_News_Filter
$INIS · $NNE 🤝 Radnostix, Inc. signed an agreement to sell its Fluorine Products/DUF6 assets to Nano Nuclear Energy Inc. Selected from hundreds of headlines
LifesGood
$INIS The main catalyst expected to push the price of Radnostix (OTCQB: INIS) is the formal closing of the $13.5 million asset sale to NANO Nuclear Energy (NNE).Here is the timeline and upcoming Press Releases (PR) to watch for:1. NANO Nuclear Deal Closing PR (Expected Late Dec 2026 – Jan 2027)The Setup: On October 1, 2026, INIS announced a definitive agreement to sell its legacy, unbuilt DUF6 and fluorine assets to NANO Nuclear for $9.5 million in cash and $4.0 million in restricted NNE stock. The Progress: On October 19, 2026, the company issued a joint PR confirming they filed a Letter of Intent with the U.S. Nuclear Regulatory Commission (NRC) for the SUB-1011 license transfer.The Driver: Filings state the transaction has a 90 to 120-day closing window from the signing date (Sept 28, 2026). A definitive Press Release confirming the final regulatory approval and receipt of the cash/equity is expected between late December 2026 and January 2027. Receiving $9.5M

Advertisement|Remove ads.